Article

A persistent rise in mortality among injection drug users in Rome, 1980 through 1992.

Department of Epidemiology, Lazio Region, Rome, Italy.
American Journal of Public Health (Impact Factor: 4.23). 06/1997; 87(5):851-3. DOI: 10.2105/AJPH.87.5.851
Source: PubMed

ABSTRACT The purpose of the study was to analyze overall and cause-specific mortality among injection drug users in Rome.
A cohort of 4200 injection drug users was enrolled in drug treatment centers from 1980 through 1988 and followed up until December 1992.
The age-adjusted mortality rate from all causes increased from 7.8/1000 person-years in 1985/86 to 27.7/1000 in 1991/92. The rise was mainly attributable to acquired immunodeficiency syndrome (AIDS), but mortality from overdose and other causes increased as well. The cumulative risk of death by the age of 40 was 29.3%.
The impact of AIDS deaths appears to be additional to a persistent increase of mortality for all other causes.

0 Bookmarks
 · 
77 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract We explored the impact of drug misuse on sudden, unexpected, violent or unnatural male deaths, checking the association between official mortality statistics, health records, and coroner evidence and verdicts. We searched health and coroner records for all Merseyside and Cheshire coroner cases for men aged 15–39 in 1995, comparing our data with government mortality statistics. We explored the relationship between accidental/undetermined and suicide verdicts, and post-mortem drug and alcohol toxicity. Our survey included 238 cases; 221 had toxicological data and formed our final sample. There was post-mortem evidence of drugs in 90 cases, alcohol in 102, and both in 46. Overdose verdicts were given for 74 cases. We found evidence of significant alcohol problems in 18 cases and drug misuse in 74. The presence of drugs at post-mortem was significantly related to a verdict of accident/undetermined rather than suicide (p = 0.03). Post-mortem Class A drug toxicity was significantly related to accidental/undetermined verdicts compared to Class B/C drugs. There was no significant relationship between the number of drugs found and the verdict. While coroners determined drugs to be related to death in 90 cases, official classifications would have recorded this figure as 60 (ONS standard) or 40 (EMCDDA—European Union recommended classification). Our findings support the recommendations of the recent ACMD report into the reduction of drug-related deaths [1].
    Drugs: Education Prevention and Policy 01/2004; 11(3):229-242. · 0.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In theory, intranasal (IN) naloxone should be effective and practical for the treatment of acute opioid overdose. To date, evaluation of its effectiveness has been limited, but what is known is promising with reports that it is effective and safe, can reduce the requirement for injected treatments and has comparable times to recovery with other routes of administration. Unfortunately, naloxone as it is currently manufactured is not ideal for IN administration, as effective doses require drug volumes in excess of recommended volumes for adequate nasal absorption. Further well-designed research is needed to confirm IN naloxone's effectiveness, adverse event profile and utility. If effectiveness and safety can be confirmed, wider distribution of naloxone treatment to community workers, family and peers may be feasible, with the potential to save lives.
  • Source

Full-text (2 Sources)

Download
25 Downloads
Available from
May 30, 2014